1)- Atefeh Basirat, Hadi Raeisi Shahraki, Hamid Reza Farpour, Leila Habibi. The Correlation between Using Social Networks and the General Health of Multiple Sclerosis Patients.Multiple sclerosis international. 2020, 2020: 2791317
2)- Ekaterina S Philippova, Igor V Bazhenov, Alexander V Ziryanov, Ekaterina Y Moskvina. Evaluation of Lower Urinary Tract Dysfunction Impact on Quality of Life in Multiple Sclerosis Patients: Russian Translation and Validation of SF-Qualiveen.Multiple sclerosis international. 2020, 2020: 4652439
3)- K Daniels, P B van der Nat, S T F M Frequin, P J van der Wees, D H Biesma, E L J Hoogervorst, E M W van de Garde. Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis.Multiple sclerosis international. 2020, 2020: 5463451
4)- Vanessa F Moreira Ferreira, Danielle Caefer, Natalie Erlich-Malona, Brian C Healy, Tanuja Chitnis, James M Stankiewicz. Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis.Multiple sclerosis international. 2020, 2020: 5471987
6)- Erin M Edwards, Deborah A Kegelmeyer, Anne D Kloos, Manon Nitta, Danya Raza, Deborah S Nichols-Larsen, Nora E Fritz. Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS.Multiple sclerosis international. 2020, 2020: 6707414
7)- Marat F Kasakin, Artem D Rogachev, Elena V Predtechenskaya, Vladimir J Zaigraev, Vladimir V Koval, Andrey G Pokrovsky. Changes in Amino Acid and Acylcarnitine Plasma Profiles for Distinguishing Patients with Multiple Sclerosis from Healthy Controls.Multiple sclerosis international. 2020, 2020: 9010937